Mannose‐Glycated Metal‐Phenolic Microcapsules Orchestrate Phenotype Switch of Macrophages for Boosting Tumor Immunotherapy
Advanced Science · 2025
DOI: 10.1002/advs.202415565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xin Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, Chi…. Hauptthemen laut MEDLINE: Macrophages, Immunotherapy, Mannose. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SEU Innovation Capability Enhancement Plan for Doctoral Students, military research project.
Abstract (Originalsprache)
Microcapsules are advancing in immunotherapy, with both their core and shell being capable of loading immunoregulatory substances. Notably, microcapsules with intrinsic bioactivities can more directly modulate the immune microenvironment, while current research in this area remains scarce. Herein, immunomodulatory metal‐phenolic microcapsules (mMPMs) is developed through the one‐step assembly of dopamine‐modified hyaluronic acid (HADA) and Fe III onto mannose‐glycated bovine serum albumin microbubbles (Man‐BSA MBs). Specifically, Man‐BSA formed during the early stages of the Maillard reaction is sonicated to produce microbubbles as templates for capsule preparation. Subsequently, HADA is rapidly coated on the templates and coordinates with Fe III to form microcapsules after air escapes from MBs. Mass spectrometry analysis identifies abundant lysine glycation sites on Man‐BSA, with the highest glycation site percentage reaching 94.88%. Man‐BSA within mMPMs effectively promotes macrophage internalization, induces the accumulation of pro‐inflammatory mediators, and thereby results in the M1 polarization of macrophages, as further corroborated by proteomic analysis. Consequently, the compelling anti‐tumor effects of mMPMs are demonstrated both in vitro and in vivo. Overall, this work presents an immunomodulatory microcapsule that activates pro‐inflammatory phenotype macrophages, which is a promising microcarrier to improve immunotherapeutic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
- School of Medicine, Southeast University, Nanjing, 210009, China.
- Department of Biliary Tract Surgery I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, 200438, China.
- Department of Head & Neck Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210029, China.
- Advanced Ocean Institute of Southeast University, Nantong, 226000, China.
ORCID-Profile: Liqin Ge
Förderung
- SEU Innovation Capability Enhancement Plan for Doctoral Students
- military research project
Zitieren
APA
Tan, X., Sheng, R., Li, W., Tao, Y., Liu, Z., Yang, N., Hashmi, S. S., Feng, F., Liu, F., & Ge, L. (2025). Mannose‐Glycated Metal‐Phenolic Microcapsules Orchestrate Phenotype Switch of Macrophages for Boosting Tumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202415565
Vancouver
Tan X, Sheng R, Li W, Tao Y, Liu Z, Yang N, et al. Mannose‐Glycated Metal‐Phenolic Microcapsules Orchestrate Phenotype Switch of Macrophages for Boosting Tumor Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202415565
BibTeX
@article{Tan2025,
author = {Tan, Xin and Sheng, Renwang and Li, Weikun and Tao, Yinghua and Liu, Zonghao and Yang, Ning and Hashmi, Syeda Safia and Feng, Feiling and Liu, Fangzhou and Ge, Liqin},
title = {Mannose‐Glycated Metal‐Phenolic Microcapsules Orchestrate Phenotype Switch of Macrophages for Boosting Tumor Immunotherapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415565}
}
EUVIMED